UNC Health is a not-for-profit medical system owned by the State of North Carolina and based in Chapel Hill, North Carolina at the University of North Carolina at Chapel Hill. It provides services throughout the Research Triangle and North Carolina.

During the past decade, UNC Healthcare conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 6 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UNC Healthcare" #1 sponsor was "University of North Carolina, Chapel Hill" with 7 trials, followed by "Pfizer" with 2 trials sponsored, "PhotoThera, Inc" with 2 trials sponsored, "Astellas Pharma Global Development, Inc." with 1 trials sponsored and "Digestive Care, Inc." with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UNC Healthcare" #1 collaborator was "North Carolina Translational and Clinical Sciences Institute" with 2 trials as a collaborator, "Leap of Faith Technologies" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "UNC Healthcare" are "COVID-19" (2 trials), "Ischemic Stroke" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Decompensated Heart Failure" (1 trials) and "Acute Ischemic Stroke" (1 trials). Many other conditions were trialed in "UNC Healthcare" in a lesser frequency.

Most popular intervention types in "UNC Healthcare" are "Drug" (9 trials), "Device" (6 trials), "Biological" (5 trials), "Behavioral" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "NeuroThera® Laser System" (2 trials), "Placebo" (2 trials), "0.9% normal saline" (1 trials), "ASP9801" (1 trials) and "COVID-19 IgM-IgG Rapid Test" (1 trials). Other intervention names were less common.

The vast majority of trials in "UNC Healthcare" are 22 trials for "All" genders.

Currently, there are NaN active trials in "UNC Healthcare". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in UNC Healthcare, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in UNC Healthcare, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".